Cabaletta Bio, Inc.

NASDAQ:CABA

Biotechnology

Healthcare
$1.06 +1.23%

+$0.04 today

Market cap
$227.58M
Beta
3.23
P/E (TTM)
-1.8
EPS (TTM)
-$1.57
52W Low $1.26High $4.23

Volume 4.13M

Average 3.33M

CABA Interest Income

Income earned on cash, deposits, and investments held by the company.

Cabaletta Bio, Inc.NASDAQ: CABA

Interest Income · Q1 FY2026 · quarter ended Mar 2026

Interest income declines year over year

Q1 FY2026 interest income of $1.08M fell 27.6% year over year, ahead of the -34.1% change in trailing-twelve-month interest income. Sequentially, it fell 18.9% from the prior quarter. Over 3 fiscal years it compounded at +73.0% a year.

Context

  • Interest income increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -27.6% holds above the trailing-twelve-month pace of -34.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.08M-18.9% QoQ
Last fiscal yearDec 2025
$6.03M-39.8% YoY
LTMMar 2026
$5.62M-34.1% YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-27.6%——
1 year-39.8%——
3-year CAGR+73.0%——
5-year CAGR——
10-year CAGR——

Interest Income history

USD · from the income statement

Latest · FY2025
6.03M USD
Year-over-year change
-39.8%
4-year CAGR
+298.1%

Interest Income vs competitors

How CABA compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -34.1% is the 5th highest of 11, against a peer median of -40.1%.
  • Over three fiscal years its annual growth of +73.0% compares with a peer median of +64.1%.
CABA Competitors
Interest Income for CABA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALLOAllogene Therapeutics, Inc.LTM Mar 2026$17.35M USD-14.3%+61.7%—
AVIRAtea Pharmaceuticals, Inc.LTM Mar 2026$14.02M USD-40.6%+13.7%—
LYELLyell Immunopharma, Inc.LTM Mar 2026$11.41M USD-45.9%+22.9%36812.9%
KYTXKyverna Therapeutics, Inc.LTM Mar 2026$8.6M USD-44.4%+152.5%—
CAPRCapricor Therapeutics, Inc.LTM Mar 2026$8.43M USD+242.7%+128.9%—
LXEOLexeo Therapeutics, Inc. Common StockLTM Mar 2026$7.09M USD-0.4%+66.6%—
CABACabaletta Bio, Inc.LTM Mar 2026$5.62M USD-34.1%+73.0%—
IMMPImmutep LimitedFY2025A$5.25M AUD+35.2%+186.0%104.1%
HUMAHumacyte, Inc.LTM Mar 2026$2.26M USD-39.6%-0.5%111.9%
PRQRProQR Therapeutics N.V.LTM Mar 2026€852.58K EUR-60.2%+176.5%6.3%
EDITEditas Medicine, Inc.LTM Mar 2026-$1.51M USD-112.9%+14.6%3.9%
Peer median (excluding CABA) —-40.1%+64.1%104.1%

Competitors are the stored peer set for CABA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development32.49M39.3M55.42M97.2M142.67M
Selling, General & Admin13.82M14.84M19.24M27.94M29.57M
Operating Expenses46.31M54.14M74.66M125.14M172.24M
Depreciation & Amortization733K1.18M1.43M1.71M1.65M
EBITDA(45.56M)(51.8M)(66.25M)(113.41M)(164.21M)
EBITDA Margin—————
Operating Income(46.31M)(54.14M)(74.66M)(125.14M)(172.24M)
Operating Margin—————
Interest Income24K1.16M6.99M10.03M6.03M
Interest Expense000748K2M
Other Income / Expenses24K1.16M6.99M9.28M4.39M
Income Before Tax(46.29M)(52.98M)(67.68M)(115.86M)(167.86M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(46.29M)(52.98M)(67.68M)(115.86M)(167.86M)
Net Margin—————
EPS (Basic)(1.80)(1.81)(1.65)(2.34)(1.64)
EPS (Diluted)(1.80)(1.81)(1.65)(2.34)(1.64)
Weighted Avg Shares25.74M29.34M40.95M49.52M102.26M
Weighted Avg Shares (Diluted)25.74M29.34M40.95M49.47M102.26M

Cabaletta Bio, Inc.

NASDAQ:CABA

Intrinsic Alpha fair value

Locked

Current Price

$1.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.